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Abstract 
In the last two decades, the use of ozone (O3) as a complementary medical approach has 
progressively been increasing; however, its application is still limited due to the numerous 
doubts about its possible toxicity, despite the low concentrations used in therapy. For an 
appropriate and safe clinical application of a potentially toxic agent such as O3, it is crucial 
to elucidate the cellular response to its administration. Molecular analyses and 
transmission electron microscopy were here combined to investigate in vitro the effects of 
O3 administration on transcriptional activity and nuclear domains organization of cultured 
SH-SY5Y neuronal cells; low O3 concentrations were used as those currently administered 
in clinical practice. Mild ozonisation did not affect cell proliferation or death, while 
molecular analyses showed an O3-induced modulation of some genes involved in the cell 
response to stress (HMOX1, ERCC4, CDKN1A) and in the transcription machinery 
(CTDSP1). Ultrastructural cytochemistry after experiments of bromouridine incorporation 
consistently demonstrated an increased transcriptional rate at both the nucleoplasmic 
(mRNA) and the nucleolar (rRNA) level. No ultrastructural alteration of nuclear domains 
was observed.  
Our molecular, ultrastructural and cytochemical data demonstrate that a mild toxic stimulus 
such as mild ozonisation stimulate cell protective pathways and nuclear transcription, 
without altering cell viability. This could possibly account for the positive effects observed 
in ozone-treated patients. 
 
Key words: ozone; human neuroblastoma cells; cell nucleus; transmission electron 
microscopy; whole gene expression 
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Abbreviations: SH-SY5Y (human neuroblastoma cell line); HMOX1 (Heme Oxygenase 
1); ERCC4 (Excision Repair Cross-Complementation Group 4); CDKN1A (Cyclin-
Dependent Kinase Inhibitor 1A) CTDSP1 (CTD Small Phosphatase 1) 
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Introduction 
Ozone (O3) is a highly unstable atmospheric gas that rapidly decomposes to normal 
oxygen (O2). Although not being a radical molecule, O3 is a very strong oxidant and, due to 
this highly toxic property, it has been widely used as a disinfectant agent, also for medical 
purposes (Travagli et al., 2010; Davies et al., 2011; Gupta et al., 2012). In addition to its 
germicidal application, O3 administration as O2-O3 gas mixture has proven to exert 
therapeutic effects in numerous diseases, including arthritis, heart and vascular diseases, 
asthma, emphysema, and multiple sclerosis (reviews in Re et al., 2008; Elvis and Ekta, 
2011; Bocci 2012). In the last two decades, the use of O3 as a complementary medical 
approach has progressively been increasing all over the world; low O3 concentrations are 
generally used in the medical practice but the application of O3 therapy is still limited due 
to the numerous doubts about its possible toxicity. Knowledge of the cellular response to 
O3 administration is therefore crucial for its appropriate and safe clinical application.  
It has been hypothesized that exposure to mild O3 concentrations may stimulate the 
cellular antioxidant defenses without inducing cell damage (Sagai and Bocci, 2011). 
Unfortunately, scientific data demonstrating activation of cytoprotective pathways are still 
scarce and inconclusive (Re et al., 2014; Güçlü et al., 2016). 
To elucidate this point, we investigated the effects of low O3 concentrations currently used 
in clinical practice on the nuclear activity of cultured cells of neuronal origin. There is, in 
fact, a growing interest for therapeutic applications of O3 to the nervous system based on 
experimental evidence that mild ozonisation induces metabolic stimulation and even 
regenerative effects in neurons (Molinari et al., 2014; Ozbay et al., 2016; Salem et al., 
2016; Tural Emon et al., 2016). The use of an in vitro model ensured controlled 
experimental conditions, allowing analysis of the direct effects of mild ozonisation on 
nuclear function without the intermediation of blood/tissue factors as occurs in vivo. 
Moreover, the choice of a stabilised neuroblastoma cell line, characterised by negligible 
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intersample variability compared to primary cell cultures, guaranteed the consistency of 
our experimental model with highly sensitive techniques such as genomic and 
ultrastructural analysis. The combination of molecular assays (microarray gene expression 
and Real Time qPCR) and microscopy techniques (transmission electron microscopy and 
ultrastructural immunocytochemistry) allowed investigation of the effects of O3 exposure 
on gene expression and the organization of nuclear domains. 
 
Materials and Methods 
Cell culture and ozone treatment 
SH-SY5Y cells (a human neuroblastoma cell line) (5x105) were seeded on 75 cm2 plastic 
flasks (Corning Inc., Corning, NY, USA) in a 1:1 mixture of EMEM (Eagle’s Minimum 
Essential Medium) and F12 medium supplemented with 10% (v/v) fetal bovine serum, 1% 
(w/v) NEAA (Non-Essential Amino Acids Solution), 0.5% (w/v) glutamine, 100 U of 
penicillin and 100 μg/mL streptomycin (Gibco by Life Technologies), at 37°C in a 5% CO2 
humidified atmosphere. When subconfluent, the cells were mildly trypsinized (0.25% 
trypsin containing 0.05% ethylene diamino tetraacetic acid (EDTA) in phosphate-buffered 
saline, PBS) and exposed in suspension to O2-O3 gas mixtures with two O3 concentrations 
successfully used for therapeutic purposes (10 and 16 µg O3/ml O2). A high concentration 
(100 µg O3/ml O2) was also used as a control for a strong oxidative stress. The gas was 
produced by an OZO2 FUTURA apparatus (Alnitec s.r.l., Cremosano, CR, Italy), which 
generates O3 from medical-grade O2, and allows photometric real-time control of gas flow 
rate and O3 concentration. The reliability of the experimental procedure was guaranteed by 
choosing a well-established technique for cell ozonisation (Larini et al., 2003), which 
ensures that a defined number of cells are exposed to an exact gas volume at a pressure 
corresponding to the atmospheric one, and that the cell sample reacts totally with the O3 
dose for a precise treatment time. Briefly, for each sample, 4x105 cells were suspended in 
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1 ml medium into a 10 ml syringe (Terumo Medical Corporation, Somerset, NJ, USA), an 
equal volume of gas was then collected in the syringe, and the sample was gently mixed 
with the gas for 10 min to allow cells to react with the O3. 
Cells exposed to pure O2 under the same experimental conditions were used to 
discriminate the effect of O3, while cells exposed to air served as control (CTR).  
Three hours after the exposure to the different gases or air, the cells were processed for 
genomic or microscopy analyses, while other samples were allowed to grow for 24 hr and 
48 hr, to estimate the effect of O3 on cell viability and proliferation (see below). For 
Western blot analysis, the cells were processed 10 min after treatment. 
 
Cell viability and proliferation 
To determine the effect of gas exposure on cell survival and growth, 5x104 cells/well were 
seeded on 6 multiwell plastic microplates (Corning), and the fraction of dead cells was 
estimated 3 h after treatment, whereas the total cell number was assessed after 24 h and 
48 h. The cells were detached by mild trypsinization as above, stained for 2 min with 0.1% 
trypan blue in the culture medium, and scored in a Burker hemocytometer using a Leica 
DM IL inverted microscope equipped with 10x objective lens. Data were expressed as the 
mean of three independent experiments ± standard error of the mean (SE).  
Results for each measured variable were pooled according to the experimental group and 
the mean  SE value calculated. Statistical comparisons were performed by the one way-
Anova test and post-hoc pairwise comparisons. 
 
RNA isolation and microarray gene expression analyses 
Three hours after gas exposure, RNA samples were extracted and purified from the cells 
by using the RNeasy Mini kit (Qiagen, Hilden, Germany) according to the manufacturer’s 
protocols. The concentration of total RNA was quantified using the Nanodrop 2000 
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(Nanodrop Technologies, Wilmington, DE, USA) by measuring the absorbance at 260 nm. 
Additionally, the OD260/230 and OD260/280 ratios were determined to assess RNA purity. 
RNA integrity was assessed with the 2100 Bioanalyzer (Agilent Technology, Santa Clara, 
CA, USA) using an RNA 6000 NanoChip and expressed as RNA Integrity Number (RIN), 
which was considered acceptable within the range of 7-10.  
RNA samples from cells treated with O2, 10 or 16 µg O3/ml O2 as well as the CTR were 
processed for transcriptomic analyses. Total RNA (250 ng) from each sample were 
reverse-transcribed with the Ambion WT Expression Kit (Invitrogen-Life Technologies, 
Carlsbad,CA, USA). Subsequently, 5.5 μg of sscDNA was fragmented and labelled with 
biotin. The labelled samples were hybridized onto Human Gene 1.1 ST Array Strips 
(Affymetrix, Inc., Santa Clara, CA, USA), comprising more than 750,000 probes and 
representing more than 28,000 genes mapped through UniGene or via RefSeq. 
The reactions of hybridization, fluidics, and imaging were performed on the Affymetrix 
Gene Atlas instrument according to the manufacturer’s instructions 
(http://www.affymetrix.com/support/technical/manuals.affx).  
The descriptive features for each identified gene were obtained from 
http://www.genecards.org. 
 
Microarray Data analysis and pathway analysis 
Affymetrix CEL files were imported into Partek Genomics Suite version 6.6 for data 
visualization and statistical testing. Quality control assessment was performed using 
Partek Genomic Suite 6.6. All the samples passed the quality criteria for hybridization 
controls, labelling controls and 3’/5’ Metrics. Background correction was conducted using 
Robust Multi-strip Average (RMA) (Irizarry et al., 2003) to remove noise from 
autofluorescence. After background correction, normalization was made using Quantiles 
Normalization (Bolstad et al., 2003) to normalize the distribution of probe intensities among 
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different microarray chips. Subsequently, a summarization step was conducted using a 
linear median polish algorithm (Tukey, 1977) to integrate probe intensities in order to 
compute the expression levels for each gene transcript. Upon data upload, pre-processing 
of CEL data for the complete data set was performed using the Robust MultiChip Average 
ANOVA statistical test to assess treatment effects. Differential gene expression was 
assessed by applying a p-value filter (for attribute=treatment) of P<0.05 to the ANOVA 
results. Contrast analyses were then performed to get the following four comparisons: 10 
μg O3/ml vs CTR, 16 μg O3/ml vs CTR, 10 μg O3/ml vs O2, 16 μg O3/ml vs O2. In this 
comparison, a maximum filter of P<0.05 and a minimum absolute fold change cut-off of 1.2 
were applied.  
In order to identify common or specific genes modulated by each treatment condition, the 
gene lists were compared by an interactive tool Venny (Venny 2.0.2 
http://bioinfogp.cnb.csic.es/tools/venny/index.html). DAVID software was used to identify 
molecular signalling pathways in each treatment conditions. 
 
Reverse transcription, RT-qPCR confirmation and statistical analysis 
One microgram of total RNA was used for cDNA synthesis with random hexamer primers 
(Invitrogen-Life Technologies) and Superscript II Reverse Transcriptase (Invitrogen-Life 
Technologies). The expression levels of specific transcripts in SH-SY5Y were determined 
by RT-qPCR using the StepOnePlus instrument (Applied Biosystems, Foster City, CA, 
USA) with the TaqMan assay (Applied Biosystems). The genes were analyzed and 
normalized to the levels of the three housekeeping (HK) genes: GAPDH (glyceraldehyde-
3-phosphate dehydrogenase, Hs04420697_g1), HPRT1 (hypoxanthine phosphoribosyl-
transferase 1, Hs99999909_m1) and UBC (ubiquitin C, Hs00824723_m1). These three HK 
genes have been chosen according to the evidence supporting that these are the best HK 
genes for neuroblastoma cell lines (Vandesompele et al., 2002). Each sample was 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
9 
 
assayed in duplicate. Data analyses were performed using the comparative Ct method 
(also known as the 2−ΔΔCt method) (Schmittgen and Livak, 2008). The differential 
expression analysis was performed by applying generalized linear model. For multiple 
comparisons, the Sidak correction was applied. SPSS vs23 was used.  
 
Western blot analysis 
NRF2, a transcription factor controlling the expression of genes coding for antioxidant and 
cytoprotective proteins (Brigelius-Flohe and Flohe, 2011), was evaluated as an index of 
cellular response to the O3 oxidant activity.  SH-SY5Y cells treated with O2, or with 10, 16 
or 100 µg O3/ml O2, as well as CTR samples were processed for Western blot analysis. 
Due to the short protein half-life (Khalil et al., 2015), cell samples were analysed 10 min 
after gas exposure. Immunoblots were performed according to standard procedures in 
RIPA buffer (150 mM NaCl, 10 mM Tris pH 7.5, 1% NP40, 1% Deoxycholate, 0.1% SDS) 
supplemented with phosphatase and protease inhibitors (Sigma, St. Louis, MO, USA). 
Samples were resolved on Tris-glicine 4-20% gradient SDS-PAGE (Bio-Rad, Hercules, 
CA, USA), blotted on Protran® membrane 0.2 μm (Whatman®) and developed with ECL 
(Amersham®). The following antibodies were used: anti-NF-E2-related factor-2 (NRF2) 
[EP1808Y] (Abcam, Cambridge, UK, #ab62352); anti-Phospho-NRF2Ser40 [EP1809Y] 
(Abcam #76026); β−Actin (Sigma). 
 
Transmission electron microscopy 
Morphological, morphometric and cytochemical analyses were carried out at transmission 
electron microscopy, in order to analyse the effects of exposure to low O3 concentrations 
on the fine nuclear features. The intranuclear distribution of the nuclear structural 
constituents involved in RNA transcription and maturation is, in fact, spatially ordered and, 
whenever RNA processing is altered, their organization, molecular composition, and 
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intranuclear location are also affected (e.g., Lafarga et al., 1993; Puvion and Puvion-
Dutilleul, 1996; Biggiogera et al., 2008; Malatesta et al., 2010). 
SH-SY5Y cells from three independent experiments were seeded on glass coverslips 
placed in 6 multiwell plastic microplates (Corning) and then processed for transmission 
electron microscopy 3 h after gas exposure: they were fixed with 4% paraformaldehyde in 
0.1 M Sörensen phosphate buffer at 4°C for 1 h, washed, treated with 0.5 M NH4Cl in 
PBS, dehydrated with ethanol and embedded in LRWhite resin. To evaluate RNA 
transcription rate, before fixation the cells were pulse-labelled with 10 mM 5-bromouridine 
(BrU, Sigma-Aldrich) for 10 min at 37°C.  
To investigate the ultrastructural morphology, some ultrathin sections were conventionally 
stained with lead citrate. A morphometric analysis was also carried out in 20 nucleoli 
(x18,000) per sample by evaluating the total area and the percentage of area occupied by 
the nucleolar components: fibrillar centers (where rDNA is located (Biggiogera et al., 2001; 
Cisterna and Biggiogera, 2010)), dense fibrillar component (where transcription and early 
splicing of pre-rRNA occur (Biggiogera et al., 2001; Cmarko et al., 2000)), and granular 
component (where pre-ribosomes are stored (Cisterna and Biggiogera, 2010)). The 
ultrastructural morphometric evaluation of the relative amounts of nucleolar components is, 
in fact, a well-established method to get information on nucleolar activity (Schwarzacher 
and Wachtler, 1993). 
Other ultrathin sections were processed for immunocytochemistry as described in 
Costanzo et al. (2015). The anti-BrdU mouse monoclonal antibody (BD Biosciences, 
Franklin Lakes, NJ, USA), which cross-reacts with BrU (Jensen et al., 1993), was used to 
identify the BrU molecules incorporated into the newly transcribed RNAs; the 
immunopositivity was revealed with a specific secondary 12 nm gold-conjugated antibody 
(Jackson Immuno Research Laboratories, West Grove, PA, USA). The samples were 
stained according to the EDTA technique that enhances the contrast of ribonucleoprotein-
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containing nuclear components, involved in RNA transcription and splicing (Bernhard, 
1969): namely, the fine fibrillar structures (named perichromatin fibrils) and the roundish 
structures (named perichromatin granules), which both occur at the edge of 
heterochromatin clumps, and the small clustered granules (named interchromatin 
granules), occurring in the interchromatin space.  
Quantitative assessment of the immunolabelling for BrU was carried out by estimating the 
gold particle density (number of gold particle/μm2) over nucleoplasmic and nucleolar areas 
on 20 randomly selected nuclei (x28,000) per sample (for technical details see Costanzo 
et al., 2015). For background evaluation, samples processed in the absence of the primary 
antibody were considered. This long-established technique (e.g. Hayat, 1992; Gingras and 
Bendayan, 1994; Cmarko et al., 1999, 2000; Malatesta et al., 2010) allows quantitative 
evaluation and statistical comparisons of the surface density of immunogold labelling in 
precise subcellular domains, thus simultaneously providing molecular and structural 
information. The same samples were used for quantitative evaluations of the nuclear 
structural constituents involved in mRNA processing that are visible only after EDTA 
staining: the size of the interchromatin granule cluster and the nucleoplasmic density of 
perichromatin granules (number of granules/µm2) were estimated. 
Results for each measured variable were pooled according to the experimental group and 
the meanSE value calculated. Statistical comparisons were performed by the one way-
Anova test and post-hoc pairwise comparisons. 
All samples were observed in a Philips Morgagni transmission electron microscope (FEI 
Company Italia Srl, Milan, Italy) operating at 80kV and equipped with a Megaview II 
camera (FEI Company Italia Srl, Milan, Italy) for digital image acquisition.  
 
Results 
Cell viability and proliferation 
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The trypan blue exclusion test demonstrated that the percentage of dead cells was similar 
in cells exposed to air, O2, 10 µg O3/ml and 16 µg O3/ml, remaining below 4% (Fig. 1a). In 
O3 100 µg/ml-treated samples the percentage of dead cells was significantly raised 
compared to all groups. 
The number of cells was similar in control and low O3 concentration-treated samples, after 
both 24 h and 48 h (Fig. 1b), which indicates that no effect on cell proliferation was 
induced by mild ozonisation.  
 
Microarray gene expression analyses 
To identify genes modulated by the two low concentrations of O3 used, microarray gene 
expression analyses were performed. We found 70 modulated genes after the 
comparisons between 10 g O3/ml O2 vs CTR, 58 genes after 16 g O3/ml O2 vs CTR, 27 
genes after 10 g O3/ml O2 vs O2 samples, and 42 genes after 16 g O3/ml O2 vs O2.  
In order to identify common or specific genes modulated by these treatment conditions, the 
equivalent gene lists were compared by using an interactive tool Venny (Fig. 2). In 
particular, we focused on those genes in common between the different comparisons. The 
results indicated that 18 modulated genes were obtained after the comparisons between 
10 g O3/ml O2 vs CTR and 16 g O3/ml O2 vs CTR (Table 1). Two of these genes 
(Heterogeneous Nuclear Ribonucleoprotein C-Like 1, HNRPCL1, and Chromosome 3 
Open Reading Frame 62, C3orf62) were down-regulated, while 16 genes were up-
regulated (Exocyst Complex Component 5, EXOC5; Transmembrane Protein 242, 
TMEM242 and 79, TMEM79; Ankyrin Repeat and SOCS Box Containing 3, ASB3; TRNA 
Methyltransferase 1 Homolog (S. Cerevisiae)-Like, TRMT1L; S100 Calcium Binding 
Protein A6, S100A6; Dermatan Sulfate Epimerase-Like, DSEL; Zinc Finger Protein 286A, 
ZNF286A; GAR1 Ribonucleoprotein, GAR1; Excision Repair Cross-Complementation 
Group 4, ERCC4; Sep (O-Phosphoserine) TRNA:Sec (Selenocysteine) TRNA Synthase, 
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SEPSECS; Catenin (Cadherin-Associated Protein), Alpha-Like 1, CTNNAL1; Integrator 
Complex Subunit 2, INTS2; Zinc Finger Protein 845, ZNF845; Solute Carrier Family 7, 
Member 11, SLC7A11). Moreover, we identified the gene Heme Oxygenase (Decycling) 1, 
HMOX1 that was up-regulated in all the O3-treated samples compared to O2-treated or 
CTR samples. Among all these genes, two are involved in stress response (ERCC4 and 
HMOX1, up-regulated), three belong to the transcription machinery (GAR1, INTS2, 
ZNF845, all up-regulated), and one (S100A6, up-regulated) is implicated in cytoskeletal 
structuring (Fig. 2).  
Furthermore, the comparisons between 16 g O3/ml O2 vs CTR and 16 g O3/ml O2 vs O2 
showed 7 commonly modulated genes (Table 1). Three of these genes are involved in 
stress response: Apoptosis Enhancing Nuclease, AEN, Cyclin-Dependent Kinase Inhibitor 
1A (P21, Cip1), CDKN1A (both up-regulated) and DEP Domain Containing MTOR-
Interacting Protein, DEPTOR (down-regulated). Two other genes belong to the 
transcription machinery: CTD (Carboxy-Terminal Domain, RNA Polymerase II, Polypeptide 
A) Small Phosphatase 1, CTDSP1 and Transcription Elongation Factor A (SII)-Like 3), 
TCEAL3 (both down-regulated) (Fig. 2). The comparisons between 10 g O3/ml O2 vs 
CTR and 10 g O3/ml O2 vs O2 showed 4 commonly modulated genes (Table 1); one of 
them - claspin CLSPN gene (up-regulated) - is involved in stress response (Fig. 2).  
In addition, we performed pathway analyses on all genes modulated by O3 both at 10 or 
16 g O3/ml O2 vs CTR or O2. The results showed that the only pathway in common 
among the four comparisons performed was the signalling associated to HMOX-1.  
 
RT-qPCR validation 
Among the genes found as significantly modulated from the microarrays data, we selected 
for validation in Real Time PCR (RT-qPCR) those that were modulated by O3-O2 treatment 
and involved in stress response and transcription machinery: HMOX1 (Hs01110251_m1), 
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ERCC4 (Hs01063530_m1), GAR1 (Hs00852376_g1), INTS2 (Hs01125681_g1), ZNF845 
(Hs00874661_g1), S100A6 (Hs01002197_g1), CLSPN (Hs00898642_g1), AEN 
(Hs00901422_m1), CDKN1A (Hs00355782_m1), DEPTOR (Hs00224437_m1), CTDSP1 
(Hs01105503_m1), TCEAL3 (Hs03056487_g1). The data obtained from these genes were 
compared with CTR, O2, 10 g O3/ml O2, 16 g O3/ml O2 and 100 g O3/ml O2. We 
considered significant after Sidak correction the data resulting from all three HK genes. 
The findings, shown in Table 2, confirmed modifications in the mRNA levels of ERCC4 
(100g O3/ml O2 vs CTR and O2); CDKN1A (16/100g O3/ml O2  vs CTR and O2); CTDSP1 
(16g O3/ml O2 vs CTR and O2) and HMOX1 (10/16/100g O3/ml O2 vs CTR and 100g 
O3/ml O2 vs O2). Furthermore, the trend in gene expression after 100g O3/ml O2 treatment 
did not differ from that observed after mild ozonisation (10 or 16g O3/ml O2).  
 
Western blot analysis 
Multiple lines of evidence have contributed to establish the notion that mild ozonisation 
might induce the transcription of anti-oxidant genes, such as HMOX1, via the activation of 
Nuclear factor (erythroid-derived 2)-like 2 (NRF2). In line with this notion, we found in O3-
treated cells a slight but dose-dependent increase of Phospo-NRF2 (S40) fraction over 
total NRF2 (Fig 3). 
 
Transmission electron microscopy  
Ultrastructural observations revealed similar morphological features of the cell nuclei in 
CTR, O2-treated, 10 µg O3/ml-treated and 16 µg O3/ml-treated cells, at 3 h post-treatment 
(Fig. 4). The cell nuclei showed roundish shape with finely irregular borders and a few 
small heterochromatin clumps associated to the nuclear periphery and the nucleoli; each 
nucleus usually contained one or two nucleoli characterized by a few fibrillar centres, and 
abundant dense fibrillar component and granular component.  
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In the nucleoplasm, EDTA staining allowed the visualization of the structural constituents 
involved in pre-mRNA transcription and processing leading to the mature mRNAs suitable 
for export to the cytoplasm. Numerous perichromatin fibrils  (the in situ form of 
transcription (Fakan, 2004), splicing (Cmarko et al., 1999) and 3’ end processing (Schul et 
al., 1996) of pre-mRNAs) and perichromatin granules  (vectors and storage sites for 
already spliced pre-mRNAs (Fakan, 2004)) were distributed at the edge of 
heterochromatin, while clusters of interchromatin granules (where storage, assembly and 
phosphorylation of transcription and splicing factors take place (Bogolyubov et al., 2009)) 
occurred in the interchromatin space (Fig. 5). No change was found in the area of 
interchromatin granules clusters and the density of perichromatin granules (Fig. 5 and 
Table 3). 
The only evident morphological differences concerned the nucleoli, which showed a rather 
compact arrangement in CTR and O2-treated cells (Fig. 3a, b), whereas being more 
reticulated, with prominent dense fibrillar component and more numerous fibrillar centres 
in both samples treated with low O3 concentrations (Fig. 4c, d). Increased percentages of 
the dense fibrillar component and fibrillar centres in the nucleoli of O3-treated cells were 
confirmed by morphometric evaluations (Table 3). 
Ultrastructural immunocytochemical analyses demonstrated that in all the cell samples 
(Fig. 5a, b) BrU incorporation occurred in perichromatin fibrils and the nucleolar dense 
fibrillar component, consistently with their role in transcription and early splicing of pre-
mRNA and pre-rRNA, respectively (Fakan, 2004; Biggiogera et al., 2001; Cmarko et al., 
2000). Quantitative evaluation revealed a significantly higher labelling density in both the 
nucleoplasm and the nucleolus of O3-treated cells. Control samples processed in the 
absence of primary antibodies revealed a negligible signal (not shown). 
 
Discussion 
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As far as we know, the present investigation is the first attempt to perform a 
comprehensive study on the effect of mild ozonisation on cell nuclear function, combining 
molecular and ultrastructural approaches. Novel information has been obtained on the 
multiple effects on some nuclear pathways of SH-SY5Y cells in response to the exposure 
to low O3 concentrations.  
Our results demonstrate that exposure of SH-SY5Y cells to 10 or 16 µg O3/ml O2 did not 
induce significant alteration of their proliferation or death rate in comparison to the CTR 
(air-exposed) or O2-treated cells. Consistently, O3 concentrations ranging from 1 to 20 
µg/ml were found not to affect viability or proliferation of human epithelial cells in vitro 
(Costanzo et al., 2015). Indeed, the low O3 concentrations used proved to affect the 
expression of some genes coding for proteins involved in the cytoprotective pathways 
(such as the regulation of DNA replication, cell cycle progression and cell death; 
prevention of oxidative stress damage; detoxification). Interestingly, HMOX1, which is 
upregulated in all the O3-treated samples, codes for a protein known to protect the cell 
from various insults (Sun et al., 2002), while inhibiting apoptosis (Brouard et al., 2000) and 
promoting angiogenesis (Grochot-Przeczek et al., 2013). HMOX1 protein is also involved 
in modulating the activation of NRF2 (Biswas et al., 2014), which controls the expression 
of genes responsible for the antioxidant response (Brigelius-Flohe and Flohe, 2011). 
Accordingly, activation of NRF2 has been reported in peripheral blood mononuclear cells 
of patients submitted to ozone therapy (Re et al., 2014), as well as in our cell samples 
exposed to O3. In particular, it has previously been reported that HMOX-1 up-regulation 
may be induced by the protein kinase C (PKC)-mediated activation of NRF2 in SH-SY5Y 
cells (Zhang et al., 2009; Quesada et al., 2011). NRF2 is amongst the major drivers of the 
antioxidant stress response and its activation is thought to underlie the beneficial effects of 
therapeutic ozonisation (Bocci and Valacchi, 2015). PKC-mediated activation of NRF2 in 
response to oxidative stress relies on the rapid and transitory phosphorylation of NRF2 on 
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the serine 40 (P-NRF2 (S40)) (Huang et al., 2000). Accordingly, we found a rapid post-
treatment increase of P-NRF2 (S40) fraction over the total Nrf2 protein (in accordance with 
the report by Khalil et al., 2015 for ovarian cancer cells). 
These findings are consistent with a primary role of HMOX1 in the cellular response 
following O3 exposure. The involvement of ERCC4 and CDKN1A genes (which are both 
up-regulated) confirms the effect of O3 on the activation of cytoprotective pathways: in fact, 
ERCC4 (belonging to the DNA nucleotide excision repair) and CDKN1A (playing a key role 
in the cellular response to stress) are both activated following DNA damage. However, the 
expression trend of these genes seems to be independent from the O3 concentration: it is 
likely that, although an oxidative stress induces up-regulation of some key genes involved 
in protective pathways, the immediate cellular defence mostly relies on translational/post-
translational mechanisms (such as Nrf2 phosphorylation). 
Our findings support the hypothesis that a mild oxidative stress would be responsible for 
the activation of cytoprotective response without cell damage and, finally, for the 
therapeutic potential of low O3 concentrations (Sagai and Bocci, 2011).  Accordingly, there 
is increasing evidence that oxidative stress may not only induce deleterious damage 
playing a causative role in various pathogenic processes (distress), but may also act as a 
beneficial messenger stimulating the cell defence capacity (eustress) (recent reviews in 
Niki, 2016; Sies, 2017). 
The O3-induced modulation of nuclear activity takes place without any concomitant cell 
damage. In particular, no modification has been observed in the organization and 
intranuclear location of ribonucleoprotein-containing nuclear structures, demonstrating that 
the chronologically- and spatially-ordered RNA processing (Biggiogera et al., 2008; 
Malatesta et al., 2010) was not affected. In addition, our microscopy and molecular data 
clearly demonstrate an increased nuclear activity in O3-treated SH-SY5Y cells. The 
changes in nucleolar architecture observed in O3-treated cells are, in fact, a cytological 
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index of nuclear activation. The nucleolus is a very dynamic structure that can rapidly 
adapt its activity, and consequently its structural organization, to the cell metabolic state: 
the enlargement of the dense fibrillar component (which is the site of rRNA synthesis and 
maturation) and the increase in number and size of fibrillar centres (containing rDNA) are 
accepted signs of increased nucleolar activity (Schwarzacher and Wachtler, 1993; 
Cisterna and Biggiogera, 2010). The enhanced transcriptional rate demonstrated by BrU 
incorporation in O3-treated cells at both the nucleoplasmic (pre-mRNA) and nucleolar 
(rRNA) level represent a further evidence of metabolic activation. 
 
Conclusions 
Taken together, our findings demonstrate that, in our experimental model, exposure to low 
O3 concentrations stimulates cell protective pathways and nuclear transcription without 
altering cell proliferation and survival. More generally, our data provide structural and 
molecular evidence for the nuclear response activated by a mild toxic stimulus: this 
probably gives rise to a cascade of molecular events through multiple cellular pathways 
that could account for the positive effects observed in ozone-treated patients. It is worth 
stressing that, in our experimental system, we used the same conditions used for the 
administration to patients, i.e. O3 was administered as O3-O2 mixture, which makes the 
observed effects reliably comparable to those occurring in cells in vivo.  
The results of the present study may contribute to fill the current lack of evidence on the 
cellular mechanisms of O3 action, thus providing a robust scientific background for its 
clinical application. In addition, the histochemical and molecular tests we used may also be 
suitable for defining protocols to test in vitro the biological effects of O3 exposure. 
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Legends 
 
Fig. 1. Effect of O3 exposure on cell death and proliferation. a) Mean values±SE of dead 
cell percentage evaluated by trypan blue staining at 3 h post-ozonisation. The values of O3 
100 µg/ml-treated cells are significantly higher compared to all groups (p<0.001). b) Mean 
values±SE of cell number 24h and 48h post-ozonisation. No significant difference has 
been found among experimental groups at the same time post-treatment 
 
Fig. 2. Common and specific genes modulated by different treatment conditions obtained 
by using the interactive tool Venny. 18 modulated common genes were obtained after the 
comparisons between 10 µg O3/ml vs CTR and 16 µg O3/ml vs CTR. Of these 18 genes, 6, 
all up-regulated (arrows), are involved in pathways potentially linked to O3 action 
mechanism: ERCC4 (stress response), GAR1, INTS2, ZNF845 (transcription machinery), 
S100A6 (cytoskeletal structure). Seven modulated common genes were obtained after the 
comparisons between 16 µg O3/ml vs CTR and 16 µg O3/ml vs O2. Of these 7 genes, 5 
belong to pathways potentially linked to O3 action mechanism: AEN, CDKN1A (both up-
regulated, arrows) and DEPTOR (down-regulated, arrow) are involved in stress response, 
CTDSP1 and TCEAL3 (both down-regulated, arrows) are involved in transcription 
machinery. Finally, 4 modulated common genes were obtained after the comparisons 10 
µg O3/ml vs CTR and 10 µg O3/ml vs O2. Of these 4 genes, CLSPN (up-regulated, arrow) 
is involved in stress response. One gene resulted up-regulated after all comparisons, 
HMOX1 resulted up-regulated after the comparisons between 16 µg O3/ml vs O2 and 10 
µg O3/ml vs O2.  
ERCC4=Excision Repair Cross-Complementation Group 4; GAR1=GAR1 
Ribonucleoprotein; INTS2=Integrator Complex Subunit 2; ZNF845=Zinc Finger Protein 
845; S100A6=S100 Calcium Binding Protein A6; HMOX1=Heme Oxygenase (Decycling) 
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1; AEN=Apoptosis Enhancing Nuclease; CDKN1A=Cyclin-Dependent Kinase Inhibitor 1A 
(P21, Cip1); DEPTOR=DEP Domain Containing MTOR-Interacting Protein; CTDSP1=CTD 
(Carboxy-Terminal Domain, RNA Polymerase II, Polypeptide A) Small Phosphatase 1; 
TCEAL3=Transcription Elongation Factor A (SII)-Like 3; CLSPN=claspin 
 
Fig. 3. Effect of O3 exposure on NRF2 activation: O3 exposure induced a dose-dependent 
increase of the fraction of NRF2 activated by the phosphorylation on Serine 40 (P-NRF2 
(S40)) over the total amount of NRF2, which did not change upon treatment. 
 
Fig. 4. Effect of O3 exposure on nuclear ultrastructure: transmission electron micrographs 
of CTR (a), O2- (b), 10µg O3- (c) and 16µg O3- (d) treated cells. Cell nuclei show similar 
features in all samples; however, in 10µg and 16µg O3-treated cells the nucleoli (Nu) 
appear more reticulated than in CTR and O2-treated cells. Inset: high magnification detail 
of a nucleolus showing the three structural components i.e., fibrillar center (FC), dense 
fibrillar component (DFC) and granular component (GC). 
 
Fig. 5. Effect of O3 exposure on RNA transcription: representative transmission electron 
micrographs of CTR (a) and 10µg O3-treated cells (b) labelled for BrU 3 h post-treatment. 
BrU molecules have been incorporated in perichromatin fibrils (arrows) and in the 
nucleolar dense fibrillar component (arrowheads). Nu, nucleolus; IG, interchromatin 
granules; open arrows, perichromatin granules. c, d) Mean±SE values of BrU labelling 
density evaluated on nucleoplasm and nucleoli. Asterisks indicate values significantly 
different from each other at the same time post-treatment 
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Table 1 Common genes modulated by different treatment conditions. 18 modulated genes 
were obtained after the comparisons between 10 µg O3/ml vs CTR and 16 µg O3/ml vs 
CTR. Seven modulated genes were obtained after the comparisons between 16 µg O3/ml 
vs CTR and 16 µg O3/ml vs O2. Four modulated genes were obtained after the 
comparisons 10 µg O3/ml vs CTR and 10 µg O3/ml vs O2. HMOX1 is a gene in common 
between the all comparisons. Each gene is linked to the respective p value and fold-
change 
GeneSy
mbol 
RefSeq chromo
some 
gene_assignment Description p-value Fold-
Change 
Description p-value Fold-
Change 
HNRNP
CL1 
BC137
258 
1p36.21 Heterogeneous nuclear 
ribonucleoprotein C-like 1 
10µgO3/ml vs 
CTR 
0.0329 -1.33389 16µgO3/ml vs 
CTR 
0.0402 -1.31 
C3orf62 AK096
799 
3p21.31 Chromosome 3 open reading frame 
62 
10µgO3/ml vs 
CTR 
0.0032 -1.2928 16µgO3/ml vs 
CTR 
0.0029 -1.30 
EXOC5 AK295
085 
14q22.3 Exocyst complex component5 10µgO3/ml vs 
CTR 
0.0289 1.20082 16µgO3/ml vs 
CTR 
0.0168 1.23 
TMEM24
2 
BC029
130 
6q25.3 Trans membrane protein 242 10µgO3/ml vs 
CTR 
0.0079 1.21959 16µgO3/ml vs 
CTR 
0.0008 1.35 
TMEM79 AK056
816 
1q22 Trans membrane protein 79 10µgO3/ml vs 
CTR 
0.0074 1.22113 16µgO3/ml vs 
CTR 
0.0009 1.33 
ASB3 BC009
569 
2p16-
p14 
Ankyrin repeat and SOCS box 
containing 3 
10µgO3/ml vs 
CTR 
0.0338 1.23517 16µgO3/ml vs 
CTR 
0.0444 1.22 
TRMT1L AF2883
99 
1q25.2 tRNA methyltransferase 1 homolog 
(S.cerevisiae)-like 
10µgO3/ml vs 
CTR 
0.0329 1.23554 16µgO3/ml vs 
CTR 
0.0284 1.24 
S100A6 BC009
017 
1q21 S100 calcium binding protein A6 10µgO3/ml vs 
CTR 
0.0442 1.24063 16µgO3/ml vs 
CTR 
0.0088 1.36 
DSEL AF4804
35 
18q22.1 Dermatan sulfate epimerase-like 10µgO3/ml vs 
CTR 
0.0004 1.26109 16µgO3/ml vs 
CTR 
0.0001 1.31 
ZNF286
A 
AF2172
26 
17p11.2 Zinc finger protein 286° 10µgO3/ml vs 
CTR 
0.0121 1.2722 16µgO3/ml vs 
CTR 
0.0265 1.22 
HMOX1 BC001
491 
22q13.1 Heme oxygenase (decycling) 1 10µgO3/ml vs 
CTR 
0.0110 1.27931 16µgO3/ml vs 
CTR 
0.0070 1.31 
GAR1 BC003
413 
4q25 GAR1 ribonucleoprotein homolog 
(yeast) 
10µgO3/ml vs 
CTR 
0.0106 1.30866 16µgO3/ml vs 
CTR 
0.0184 1.27 
ERCC4 AK289
726 
16p13.12 Excision repair cross-complementing 
rodent repair deficiency, comp 
10µgO3/ml vs 
CTR 
0.0321 1.31274 16µgO3/ml vs 
CTR 
0.0234 1.34 
SEPSEC
S 
AF2820
65 
4p15.2 Sep (O-phosphoserine) tRNA:Sec 
(selenocysteine) tRNA synthase 
10µgO3/ml vs 
CTR 
0.0140 1.31968 16µgO3/ml vs 
CTR 
0.0250 1.28 
CTNNAL
1 
AK022
834 
9q31.2 Catenin (cadherin-associated 
protein), alpha-like 1 
10µgO3/ml vs 
CTR 
0.0012 1.32244 16µgO3/ml vs 
CTR 
0.0044 1.25 
INTS2 AK299
032 
17q23.2 Integrator complex subunit 2 10µgO3/ml vs 
CTR 
0.0030 1.34448 16µgO3/ml vs 
CTR 
0.0044 1.32 
ZNF845 AK295
079 
19q13.42 Zinc finger protein 845 10µgO3/ml vs 
CTR 
0.0267 1.39489 16µgO3/ml vs 
CTR 
0.0316 1.38 
ANGPTL
4 
AF2026
36 
19p13.3 angiopoietin-like 4 10µgO3/ml vs 
CTR 
0.0318 1.41318 16µgO3/ml vs 
CTR 
0.0465 1.37 
SLC7A1
1 
AF2528
72 
4q28.3 Solute carrier family 
7(anionicaminoacidtransporterlightch
ain,xc-system), member 11 
10µgO3/ml vs 
CTR 
0.0145 1.65197 16µgO3/ml vs 
CTR 
0.0341 1.51 
TOP3A BC051
748 
17p12-
p11.2 
Topoisomerase (DNA) III alpha 10µgO3/ml vs 
O2 
0.0242 1.23706    
HMOX1 BC001
491 
22q13.1 Heme oxygenase (decycling) 1 10µgO3/ml vs 
O2 
0.0187 1.24632 16µgO3/ml vs 
O2 
0.0117 1.27 
CSPP1 AJ5834
33 
8q13.2 Centrosome and spindle pole 
associated protein 1 
10µgO3/ml vs 
O2 
0.0140 1.2645 16µgO3/ml vs 
O2 
0.0247 1.23 
SLC41A
2 
BC036
734 
12q23.3 Solute carrier family 41, member 2 10µgO3/ml vs 
O2 
0.0096 1.28212    
CLSPN AF2978
66 
1p34.2 claspin 10µgO3/ml vs 
O2 
0.0268 1.28803    
ZP3 BC113
949 
7q11.23 Zona pellucida glycoprotein 3(sperm 
receptor) 
10µgO3/ml vs 
O2 
0.0009 1.29334    
DEPTO BC024 8q24.12 DEP domain containing MTOR-    16µgO3/ml vs 0.0120 -1.39 
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R 746 interacting protein O2 
CTDSP1 AF2291
62 
2q35 CTD (carboxy-terminal domain, RNA 
polymerase II,polypeptideA) Small 
Phosphatase 1 
   16µgO3/ml vs 
O2 
0.0087 -1.28 
TCEAL3 BC008
703 
Xq22.2 Transcription elongation factor A(SII)-
like 3 
   16µgO3/ml vs 
O2 
0.0141 -1.21 
AEN BC020
988 
15q26.1 Apoptosis enhancing nuclease    16µgO3/ml vs 
O2 
0.0133 1.25 
SNORA
70D 
NR_03
3337 
16q22.3 Small nucleolar RNA, H    16µgO3/ml vs 
O2 
0.0113 1.29 
FAM179
B 
BX648
723 
14q21.2 Family with sequence similarity 179, 
member B 
   16µgO3/ml vs 
O2 
0.0065 1.38 
CDKN1A BC000
312 
6p21.2 cyclin-dependent kinase inhibitor 1A 
(p21,Cip1) 
   16µgO3/ml vs 
O2 
0.0125 1.57 
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Table 2. List of significant modulated genes after RT-qPCR 
   
 Comparisons vs CTR 
 
Comparisons vs O2 
Genes HK Groups  
2
-
DDCt
 
SEM  B 
Err 
Dev 
Wald 
95% CI 
Wald 

2
 
df p 
p 
Sidak  
2
-
DDCt
 
SEM  B 
Err 
Dev 
Wald 
95% CI 
Wald 

2
 
df p 
p 
Sidak 
ERCC4 HPRT1 
 
 
  
 
    
19,24 4 0,001 
    
 
    
19,41 3 
2E-
04  
  
[CTR]  0,00 0,06  0,00 
          
 
        
  
[O2]  0,11 0,06  
-
0,14 
0,25 
-
0,64 
0,35 0,33 1 0,57 0,96 
 
0,00 0,06  0,00 
       
  
[O3_10]  0,49 0,01  
-
0,57 
0,25 
-
1,07 
-
0,08 
5,13 1 0,02 0,09 
 
0,34 0,01  
-
0,43 
0,20 
-
0,82 
-
0,03 
4,54 1 0,03 0,10 
  
[O3_16]  0,32 0,10  
-
0,40 
0,25 
-
0,89 
0,10 2,46 1 0,12 0,39 
 
0,19 0,10  
-
0,25 
0,20 
-
0,64 
0,14 1,57 1 0,21 0,51 
  
[O3_100]  1,00 0,20  
-
1,00 
0,25 
-
1,49 
-
0,51 
15,72 1 
7E-
05 
3E-04 
 
0,81 0,20  
-
0,86 
0,20 
-
1,25 
-
0,46 
18,24 1 
2E-
05 
6E-05 
 
GADPH 
 
 
  
 
    
15,85 4 0,003 
    
 
    
13,92 3 0,003 
 
  
[CTR]  0,00 0,07  0,00 
          
 
        
  
[O2]  0,05 0,05  
-
0,07 
0,26 
-
0,58 
0,45 0,06 1 0,80 1,00 
 
0,00 0,05  0,00 
       
  
[O3_10]  0,52 0,03  
-
0,60 
0,26 
-
1,12 
-
0,09 
5,28 1 0,02 0,08 
 
0,45 0,03  
-
0,54 
0,22 
-
0,97 
-
0,10 
5,87 1 0,02 0,05 
  
[O3_16]  0,39 0,03  
-
0,48 
0,26 
-
0,99 
0,04 3,30 1 0,07 0,25 
 
0,33 0,03  
-
0,41 
0,22 
-
0,85 
0,02 3,44 1 0,06 0,18 
  
[O3_100]  0,84 0,11  
-
0,88 
0,26 
-
1,39 
-
0,36 
11,17 1 
8E-
04 
0,003 
 
0,76 0,11  
-
0,81 
0,22 
-
1,25 
-
0,38 
13,41 1 
3E-
04 
0,001 
 
UBC 
 
 
  
 
    
48,30 4 
8E-
10     
 
    
56,12 3 
4E-
12  
  
[CTR]  0,00 0,04  0,00 
          
 
        
  
[O2]  
-
0,01 
0,04  0,01 0,23 
-
0,45 
0,46 0,00 1 0,97 1,00 
 
0,00 0,04  0,00 
       
  
[O3_10]  0,28 0,01  
-
0,35 
0,23 
-
0,81 
0,10 2,31 1 0,13 ,423 
 
0,28 0,01  
-
0,36 
0,20 
-
0,74 
0,02 3,40 1 0,07 0,18 
  
[O3_16]  0,32 0,01  
-
0,40 
0,23 
-
0,85 
0,06 2,90 1 0,09 ,310 
 
0,32 0,01  
-
0,40 
0,20 
-
0,79 
-
0,02 
4,25 1 0,04 0,11 
  
[O3_100]  1,62 0,06  
-
1,39 
0,23 
-
1,84 
-
0,93 
35,74 1 
2E-
09 
9E-09 
 
1,63 0,06  
-
1,40 
0,20 
-
1,78 
-
1,01 
50,87 1 
1E-
12 
3E-12 
CDKN1A HPRT1 
 
 
  
 
    
20,93 4 
3E-
04     
 
    
15,57 3 0,001 
 
  
[CTR]  0,00 0,03  0,00 
          
 
        
  
[O2]  0,14 0,05  
-
0,19 
0,30 
-
0,78 
0,41 0,39 1 0,53 0,95 
 
0,00 0,05  0,00 
       
  
[O3_10]  0,56 0,03  
-
0,64 
0,30 
-
1,23 
-
0,04 
4,40 1 0,04 0,14 
 
0,36 0,03  
-
0,45 
0,26 
-
0,96 
0,07 2,90 1 0,09 0,24 
  
[O3_16]  0,87 0,08  
-
0,90 
0,30 
-
1,50 
-
0,31 
8,87 1 0,003 0,01 
 
0,64 0,08  
-
0,72 
0,26 
-
1,23 
-
0,20 
7,39 1 0,01 0,02 
  
[O3_100]  1,04 0,18  
-
1,19 
0,30 
-
1,78 
-
0,59 
15,25 1 
9E-
05 
4E-04 
 
0,79 0,10  
-
1,00 
0,26 
-
1,51 
-
0,48 
14,34 1 
2E-
04 
5E-04 
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GADPH 
 
 
  
 
    
25,52 4 
4E-
05     
 
    
21,24 3 
9E-
05  
  
[CTR]  0,00 0,04  0,00 
          
 
        
  
[O2]  0,08 0,05  
-
0,11 
0,27 
-
0,65 
0,43 0,16 1 0,69 0,99 
 
0,00 0,05  0,00 
       
  
[O3_10]  0,59 0,04  
-
0,67 
0,27 
-
1,21 
-
0,13 
5,93 1 0,01 0,06 
 
0,47 0,04  
-
0,56 
0,23 
-
1,01 
-
0,11 
5,89 1 0,02 0,04 
  
[O3_16]  0,98 0,04  
-
0,99 
0,27 
-
1,53 
-
0,45 
12,89 1 
3E-
04 
1E-03 
 
0,84 0,04  
-
0,88 
0,23 
-
1,33 
-
0,43 
14,49 1 
1E-
04 
4E-04 
  
[O3_100]  1,09 0,08  
-
1,06 
0,27 
-
1,60 
-
0,53 
14,99 1 
1E-
04 
4E-04 
 
0,94 0,08  
-
0,95 
0,23 
-
1,41 
-
0,50 
17,16 1 
3E-
05 
1E-04 
 
UBC 
 
 
  
 
    
50,90 4 
2E-
10     
 
    
51,61 3 
4E-
11  
  
[CTR]  0,00 0,01  
           
 
        
  
[O2]  0,03 0,04  
-
0,04 
0,26 
-
0,55 
0,48 0,02 1 0,89 1,00 
 
0,00 0,04  0,00 
       
  
[O3_10]  0,34 0,02  
-
0,42 
0,26 
-
0,93 
0,10 2,55 1 0,11 0,37 
 
0,30 0,02  
-
0,38 
0,23 
-
0,83 
0,06 2,86 1 0,09 0,25 
  
[O3_16]  0,87 0,01  
-
0,90 
0,26 
-
1,42 
-
0,39 
11,89 1 
6E-
04 
2E-03 
 
0,83 0,01  
-
0,87 
0,23 
-
1,31 
-
0,43 
14,73 1 
1E-
04 
4E-04 
  
[O3_100]  1,98 0,02  
-
1,57 
0,26 
-
2,09 
-
1,06 
35,99 1 
2E-
09 
8E-09 
 
1,90 0,02  
-
1,54 
0,23 
-
1,98 
-
1,09 
46,20 1 
1E-
11 
3E-11 
CTDSP1 HPRT1 
 
 
  
 
    
16,55 4 0,002 
    
 
    
10,65 3 0,01 
 
  
[CTR]  0,00 0,05  0,00 
          
 
        
  
[O2]  
-
0,02 
0,03  0,03 0,30 
-
0,56 
0,62 0,01 1 0,92 1,00 
 
0,00 0,03  0,00 
       
  
[O3_10]  
-
0,30 
0,03  0,52 0,30 
-
0,07 
1,11 3,00 1 0,08 0,29 
 
-
0,29 
0,03  0,49 0,31 
-
0,11 
1,10 2,55 1 0,11 0,30 
  
[O3_16]  
-
0,51 
0,09  1,03 0,30 0,44 1,62 11,59 1 
7E-
04 
0,003 
 
-
0,50 
0,09  1,00 0,31 0,39 1,60 10,45 1 0,001 0,004 
  
[O3_100]  
-
0,36 
0,20  0,64 0,30 0,05 1,23 4,48 1 0,03 0,13 
 
-
0,34 
0,20  0,61 0,31 0,00 1,22 3,90 1 0,05 0,14 
 
GADPH 
 
 
  
 
    
13,83 4 0,008 
    
 
    
7,68 3 0,05 
 
  
[CTR]  0,00 0,05  0,00 
          
 
        
  
[O2]  
-
0,07 
0,01  0,11 0,31 
-
0,50 
0,71 0,12 1 0,73 0,99 
 
0,00 0,01  0,00 
       
  
[O3_10]  
-
0,29 
0,04  0,49 0,31 
-
0,12 
1,10 2,51 1 0,11 0,38 
 
-
0,23 
0,04  0,38 0,32 
-
0,25 
1,01 1,42 1 0,23 0,55 
  
[O3_16]  
-
0,48 
0,04  0,95 0,31 0,34 1,55 9,33 1 0,002 0,01 
 
-
0,44 
0,04  0,84 0,32 0,21 1,47 6,78 1 0,01 0,03 
  
[O3_100]  
-
0,41 
0,09  0,76 0,31 0,15 1,37 6,03 1 0,01 0,05 
 
-
0,36 
0,09  0,65 0,32 0,02 1,28 4,12 1 0,04 0,12 
 
UBC 
 
 
  
 
    
15,72 4 0,003 
    
 
    
9,35 3 0,03 
 
  
[CTR]  0,00 0,03  0,00 
          
 
        
  
[O2]  
-
0,12 
0,01  0,18 0,31 
-
0,42 
0,78 0,36 1 0,55 0,96 
 
0,00 0,01  0,00 
       
  
[O3_10]  
-
0,40 
0,02  0,74 0,31 0,14 1,34 5,90 1 0,02 0,06 
 
-
0,32 
0,02  0,56 0,32 
-
0,08 
1,19 2,98 1 0,08 0,23 
  
[O3_16]  - 0,01  1,03 0,31 0,43 1,63 11,34 1 0,001 0,003 
 
- 0,01  0,85 0,32 0,21 1,48 6,82 1 0,01 0,03 
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0,51 0,44 
  
[O3_100]  
-
0,16 
0,04  0,25 0,31 
-
0,35 
0,85 0,67 1 0,41 0,88 
 
-
0,05 
0,04  0,07 0,32 
-
0,57 
0,70 0,04 1 0,83 1,00 
HMOX1 HPRT1 
 
 
  
 
    
21,73 4 
2E-
04     
 
    
8,43 3 0,04 
 
  
[CTR]  0,00 0,07  0,00 
          
 
        
  
[O2]  0,38 0,02  
-
0,46 
0,52 
-
1,48 
0,55 0,80 1 0,37 0,84 
 
0,00 0,02  0,00 
       
  
[O3_10]  2,35 0,01  
-
1,75 
0,52 
-
2,76 
-
0,73 
11,27 1 0,001 0,003 
 
1,43 0,01  
-
1,28 
0,56 
-
2,38 
-
0,18 
5,19 1 0,02 0,07 
  
[O3_16]  1,79 0,07  
-
1,48 
0,52 
-
2,50 
-
0,46 
8,09 1 0,004 0,02 
 
1,02 0,07  
-
1,01 
0,56 
-
2,12 
0,09 3,25 1 0,07 0,20 
  
[O3_100]  2,93 0,08  
-
1,98 
0,52 
-
2,99 
-
0,96 
14,45 1 
1E-
04 
0,001 
 
1,85 0,08  
-
1,51 
0,56 
-
2,61 
-
0,41 
7,23 1 0,01 0,02 
 
GADPH 
 
 
  
 
    
28,17 4 
1E-
05     
 
    
11,53 3 0,01 
 
  
[CTR]  0,00 0,08  0,00 
          
 
        
  
[O2]  0,31 0,03  
-
0,39 
0,46 
-
1,28 
0,51 0,71 1 0,40 0,87 
 
0,00 0,03  0,00 
       
  
[O3_10]  2,43 0,03  
-
1,78 
0,46 
-
2,68 
-
0,88 
15,04 1 
1E-
04 
4E-04 
 
1,62 0,03  
-
1,39 
0,49 
-
2,36 
-
0,42 
7,96 1 0,005 0,01 
  
[O3_16]  1,95 0,05  
-
1,56 
0,46 
-
2,46 
-
0,66 
11,59 1 
7E-
04 
0,003 
 
1,26 0,05  
-
1,18 
0,49 
-
2,14 
-
0,21 
5,67 1 0,02 0,05 
  
[O3_100]  2,62 0,24  
-
1,85 
0,46 
-
2,75 
-
0,96 
16,36 1 
5E-
05 
2E-04 
 
1,77 0,24  
-
1,47 
0,49 
-
2,44 
-
0,50 
8,86 1 0,003 0,01 
 
UBC 
 
 
  
 
    
30,83 4 
3E-
06     
 
    
14,74 3 0,002 
 
  
[CTR]  0,00 0,05  0,00 
          
 
        
  
[O2]  0,24 0,04  
-
0,31 
0,49 
-
1,28 
0,66 0,40 1 0,53 0,95 
 
0,00 0,04  0,00 
       
  
[O3_10]  1,88 0,02  
-
1,53 
0,49 
-
2,49 
-
0,56 
9,58 1 0,002 0,01 
 
1,32 0,02  
-
1,22 
0,54 
-
2,27 
-
0,16 
5,10 1 0,02 0,07 
  
[O3_16]  1,79 0,03  
-
1,48 
0,49 
-
2,44 
-
0,51 
8,98 1 0,003 0,01 
 
1,25 0,03  
-
1,17 
0,54 
-
2,22 
-
0,11 
4,70 1 0,03 0,09 
  
[O3_100]  4,15 0,21  
-
2,36 
0,49 
-
3,33 
-
1,40 
22,98 1 
2E-
06 
7E-06 
 
3,15 0,21  
-
2,05 
0,54 
-
3,11 
-
1,00 
14,54 1 
1E-
04 
4E-04 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
37 
 
Table 3  Means±SD values of nucleolar variables at 3 h post-ozonisation. Values identified 
by asterisks are significantly different from CTR and O2-treated samples at the same time 
post-treatment. IG, interchromatin granules; PG, perichromatin granules; DFC, dense 
fibrillar component; FC, fibrillar center; GC, granular component 
 
 
 
 
3 h post-treatment IG cluster  
area (m
2
) 
PG density 
(nr PG/m
2
) 
Nucleolar area 
(m
2
) 
% DFC  % FC  % GC 
CTR cells 
O2-treated cells 
10 µg O3-treated cells 
16 µg O3-treated cells 
0.180.10 
0.160.12 
0.150.09 
0.130.08 
3.121.52 
3.381.41 
3.411.68 
2.841.20 
5.073.22 
4.893.17 
6.424.01 
6.233.39 
31.043.88 
29.276.64 
39.683.79* 
38.404.82* 
3.611.32 
2.991.85 
4.882.63* 
4.222.03* 
65.007.53 
67.828.25 
55.656.30* 
57.495.82* 
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Highlights 
 
 low ozone concentrations induce modulation of genes involved in cell stress response 
 low ozone concentrations induce modulation of genes involved in RNA transcription 
 low ozone concentrations increase the transcriptional rate 
 low ozone concentrations do not alter the ultrastructure of nuclear domains  
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